Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-26 5:05 pm Sale |
2023-06-22 | 13G | Roivant Sciences Ltd. ROIV |
VIKING GLOBAL INVESTORS LP | 75,238,700 9.900% |
-13,000,000 (-14.73%) |
Filing History |
| 2023-06-20 4:30 pm Purchase |
2023-06-07 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
VIKING GLOBAL INVESTORS LP | 6,524,565 7.980% |
6,524,565 (New Position) |
Filing History |
| 2023-06-16 4:17 pm Unchanged |
2023-06-15 | 13D | Cazoo Group Ltd CZOO |
VIKING GLOBAL INVESTORS LP | 30,000 7.200% |
0 (Unchanged) |
Filing History |
| 2023-06-05 5:00 pm Purchase |
2023-05-26 | 13G | Verastem, Inc. VSTM |
VIKING GLOBAL INVESTORS LP | 1,320,656 7.900% |
1,320,656 (New Position) |
Filing History |
| 2023-05-16 5:27 pm Unchanged |
2023-05-12 | 13D | Cazoo Group Ltd CZOO |
VIKING GLOBAL INVESTORS LP | 30,000 7.200% |
0 (Unchanged) |
Filing History |
| 2023-04-27 4:30 pm Unchanged |
2023-04-25 | 13D | Cazoo Group Ltd CZOO |
VIKING GLOBAL INVESTORS LP | 30,000 7.200% |
0 (Unchanged) |
Filing History |
| 2023-03-21 4:46 pm Unchanged |
2023-03-17 | 13D | Cazoo Group Ltd CZOO |
VIKING GLOBAL INVESTORS LP | 30,000 7.200% |
0 (Unchanged) |
Filing History |
| 2023-02-27 5:10 pm Purchase |
2023-02-27 | 13D | Cazoo Group Ltd CZOO |
VIKING GLOBAL INVESTORS LP | 30,000 7.200% |
30,000 (New Position) |
Filing History |
| 2023-02-14 1:18 pm Purchase |
2022-12-31 | 13G | Pharvaris N.V. PHVS |
VIKING GLOBAL INVESTORS LP | 3,231,923 9.700% |
776,387 (+31.62%) |
Filing History |
| 2023-02-14 1:18 pm Sale |
2022-12-31 | 13G | Guardant Health, Inc. GH |
VIKING GLOBAL INVESTORS LP | 4,107,644 4.000% |
-1,014,851 (-19.81%) |
Filing History |
| 2023-02-14 1:18 pm Sale |
2022-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
VIKING GLOBAL INVESTORS LP | 4,634,606 7.000% |
-1,135,930 (-19.68%) |
Filing History |
| 2023-02-14 1:18 pm Purchase |
2022-12-31 | 13G | Trevi Therapeutics, Inc. TRVI |
VIKING GLOBAL INVESTORS LP | 6,162,362 9.990% |
177,628 (+2.97%) |
Filing History |
| 2023-02-14 1:18 pm Purchase |
2022-12-31 | 13G | Inhibrx Biosciences, Inc. INBX |
VIKING GLOBAL INVESTORS LP | 6,639,199 15.200% |
1,333,333 (+25.13%) |
Filing History |
| 2023-02-14 1:18 pm Sale |
2022-12-31 | 13G | FIGS, Inc. FIGS |
VIKING GLOBAL INVESTORS LP | 0 0.000% |
-13,340,414 (Position Closed) |
Filing History |
| 2023-02-14 1:18 pm Purchase |
2022-12-31 | 13G | APi Group Corporation APG |
VIKING GLOBAL INVESTORS LP | 42,095,793 17.400% |
632,379 (+1.53%) |
Filing History |
| 2023-02-14 1:18 pm Purchase |
2022-12-31 | 13G | Standard BioTools Inc. LAB |
VIKING GLOBAL INVESTORS LP | 8,323,821 9.500% |
8,323,821 (New Position) |
Filing History |
| 2023-02-14 1:18 pm Purchase |
2022-12-31 | 13G | Ginkgo Bioworks Holdings, Inc. DNA |
VIKING GLOBAL INVESTORS LP | 3,577,128 9.360% |
700,025 (+24.33%) |
Filing History |
| 2023-02-14 1:18 pm Sale |
2022-12-31 | 13G | Coupa Software Incorporated COUP |
VIKING GLOBAL INVESTORS LP | 0 0.000% |
-4,168,030 (Position Closed) |
Filing History |
| 2023-02-14 1:18 pm Sale |
2022-12-31 | 13G | PepGen Inc. PEPG |
VIKING GLOBAL INVESTORS LP | 1,544,631 6.500% |
-249,292 (-13.90%) |
Filing History |
| 2023-02-14 1:18 pm Sale |
2022-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
VIKING GLOBAL INVESTORS LP | 0 0.000% |
-2,366,385 (Position Closed) |
Filing History |